Edition:
United States

C-Rad AB (CRADb.ST)

CRADb.ST on Stockholm Stock Exchange

30.40SEK
14 Dec 2017
Change (% chg)

0.40kr (+1.33%)
Prev Close
30.00kr
Open
29.90kr
Day's High
30.40kr
Day's Low
29.50kr
Volume
42,732
Avg. Vol
149,494
52-wk High
39.50kr
52-wk Low
11.20kr

Chart for

About

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.86
Market Cap(Mil.): kr860.06
Shares Outstanding(Mil.): 28.67
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-C-Rad Updates On Delivery To Swedish Cancer Center

* REG-UPDATE ON C-RAD DELIVERY OF ITS ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA

Dec 13 2017

BRIEF-C-Rad Q3 operating loss at SEK 1.4 million

* Q3 ORDER INTAKE SEK 55.5‍​ MILLION VERSUS SEK 28.2 MILLION YEAR AGO

Oct 27 2017

BRIEF-C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna

* C-RAD TO SUPPLY ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA

Aug 03 2017

BRIEF-C-Rad to provide solutions to University Medical Center Freiburg

* UNIVERSITY MEDICAL CENTER FREIBURG, GERMANY DECIDES FOR C-RAD’S INNOVATIVE SIGRT SOLUTION

Jul 21 2017

BRIEF-C-Rad receives an order from two cancer centres in France

* CANCER CENTERS IN FRANCE DECIDE FOR C-RAD’S INNOVATIVE SIGRT SOLUTION

Jun 28 2017

BRIEF-C-Rad: ‍Patent and Market appeal court confirms right to invention ​

* ‍PATENT AND MARKET APPEAL COURT CONFIRMED IN ITS JUDGMENT C-RAD'S RIGHT TO INVENTION NAMED "PATIENT MONITORING RADIATION MACHINES"​

Jun 20 2017

Earnings vs. Estimates